SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Andrew SE, Peters AC. DNA instability and human disease. Am J Pharmacogenomics. 2001; 1: 2128.
  • 2
    Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science. 1995; 268: 13361338.
  • 3
    Myeroff LL, Parsons R, Kim SJ, et al. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 1995; 55: 55455547.
  • 4
    Parsons R, Myeroff LL, Liu B, et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 1995; 55: 55485550.
  • 5
    Oliveira C, Seruca R, Seixas M, et al. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different target genes—a study of the TGFβ RII, IGFII R and BAX genes. Am J Pathol. 1998; 153: 12111219.
  • 6
    Wu MS, Lee CW, Sheu JC, et al. Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis. Hepatogastroenterology. 2002; 49: 285289.
  • 7
    Halling KC, Harper J, Moskaluk CA, et al. Origin of microsatellite instability in gastric cancer. Am J Pathol. 1999; 155: 205211.
  • 8
    Ijichi H, Ikenoue T, Kato N, et al. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. Biochem Biophys Res Commun. 2001; 289: 350357.
  • 9
    Chang J, Park K, Bang YJ, et al. Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res. 1997; 57: 28562859.
  • 10
    Park K, Kim SJ, Bang YJ, et al. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA. 1994; 91: 87728776.
  • 11
    Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet. 1995; 9: 4855.
  • 12
    Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 1997; 57: 47494756.
  • 13
    Macdonald GA, Greenson JK, Saito K, et al. Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occur during hepatic carcinogenesis. Hepatology. 1998; 28: 9097.
  • 14
    Nagai M, Kawarada Y, Watanabe M, et al. Analysis of microsatellite instability, TGF-beta type II receptor gene mutations and hMSH2 and hMLH1 allele losses in pancreaticobiliary maljunction-associated biliary tract tumours. Anticancer Res. 1999; 19: 17651768.
  • 15
    Kidd M, Modlin IM, Lye KD, Hinoue T. The TGF beta-1 signaling pathway, mitogenic and fibrotic pathways in ileal carcinoids [abstract]. Gastroenterology. 2003; 122:4 Suppl.( ): S1004.
  • 16
    Furuta K, Misao S, Takahashi K, et al. Gene mutation of transforming growth factor beta1 type II receptor in hepatocellular carcinoma. Int J Cancer. 1999; 81: 851853.
  • 17
    Park K, Kin S-J, Bang Y-J, et al. Genetic changes in the transforming growth factor (TGF-β) type II receptor in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA. 1994; 91: 87728776.
  • 18
    Myeroff LL, Parsons R, Kim SJ, et al. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 1995; 55: 55455547.
  • 19
    Levenson A, Svoboda K, Pease K, et al. Gene expression profiles with activation of the estrogen receptor α-selective estrogen receptor modulator complex in breast cancer cells expressing the wild-type estrogen receptor. Cancer Res. 2002; 62: 44194426.
  • 20
    Camp R, Dolled-Filhart M, King B, Rimm D. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of Her2 expression are associated with poor outcome. Cancer Res. 2003; 63: 14451448.
  • 21
    Camp R, Chung G, Rimm D. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002; 8: 13231328.
  • 22
    Camp R, Charette L, Rimm D. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000; 80: 19431949.
  • 23
    Hoang JM, Cottu PH, Benedicte T, et al. Bat-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res. 1997; 57: 300303.
  • 24
    Zhou XP, Hoang JM, Cottu P, Thomas G, Hamelin R. Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene. 1997; 15: 17131718.
  • 25
    Halling KC, Harper J, Moskaluk CA, et al. Origin of microsatellite instability in gastric cancer. Am J Pathol. 1999; 155: 205211.
  • 26
    Jakobovitz O, Nass D, DeMarco L, et al. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab. 1996; 81: 31643167.
  • 27
    Ghimenti C, Lonobile A, Campani D, Bevilacqua G, Caligo MA. Microsatellite instability and allelic losses in neuroendocrine tumors of the gastro-entero-pancreatic system. Int J Oncol. 1999; 15: 361366.
  • 28
    Arnold CA, Sosnowski A, Blum HE. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system. Ann N Y Acad Sci. 2004; 1014: 218219.
  • 29
    Muneyuki T, Watanabe M, Yamanaka M, et al. Combination analysis of genetic alterations and cell proliferation in small intestinal carcinomas. Dig Dis Sci. 2000; 45: 20222028.
  • 30
    Planck M, Ericson K, Piotrowska Z, et al. Microsatellite instability and expression of MKH1 and MSH2 in carcinomas of the small bowel. Cancer. 2003; 97: 15511557.
  • 31
    Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58: 52485257.